SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
Marsh & McLennan Companies, Inc. (MMC) trades at a trailing P/E of 21.7, forward P/E of 17.7. Trailing earnings yield is 4.61%, forward earnings yield 5.64%. PEG 6.99.
Criteria proven by this page:
- VALUE (67/100, Pass) — P/E is below market average (21.7); earnings yield beats bond yields (4.61%).
- Forward P/E 17.7 (down from trailing 21.7) — analysts expect earnings to grow, which would improve the valuation.
- PEG Ratio 6.99 — above 2.0 suggests expensive relative to earnings growth.
- Trailing Earnings Yield 4.61% — roughly competitive with bond yields (~4.3%), moderate risk-reward. Forward yield improves to 5.64% as earnings recover.
- Analyst consensus target $199.35 (+9.1% upside) — modest upside expected.
Overall SharesGrow Score: 60/100 with 4/7 criteria passed.
SharesGrow 7-Criteria Score
✓
VALUE
67/100
Price-to-Earnings & upside
Proven by this page
✗
HEALTH
33/100
Debt-to-Equity & liquidity
→ Health
Valuation Snapshot — MMC
Valuation Multiples
P/E (TTM)21.7
Forward P/E17.7
PEG Ratio6.99
Forward PEG0.79
P/B Ratio0.00
P/S Ratio3.35
EV/EBITDA0.0
Per Share Data
EPS (TTM)$8.43
Forward EPS (Est.)$10.31
Book Value / Share$0.00
Revenue / Share$54.62
FCF / Share$0.00
Yields & Fair Value
Earnings Yield4.61%
Forward Earnings Yield5.64%
Dividend Yield0.00%
Analyst Target$199.35 (+9.1%)
P/E Ratio & Earnings Yield
Earnings Per Share (EPS) History
| Year |
EPS (Diluted) |
Revenue |
Net Income |
Net Margin |
| 2016 |
$3.37 |
$13.21B |
$1.77B |
13.4% |
| 2017 |
$2.87 |
$14.02B |
$1.49B |
10.6% |
| 2018 |
$3.23 |
$14.95B |
$1.65B |
11% |
| 2019 |
$3.41 |
$16.65B |
$1.74B |
10.5% |
| 2020 |
$3.94 |
$17.22B |
$2.02B |
11.7% |
| 2021 |
$6.13 |
$19.82B |
$3.14B |
15.9% |
| 2022 |
$6.04 |
$20.72B |
$3.05B |
14.7% |
| 2023 |
$7.53 |
$22.74B |
$3.76B |
16.5% |
| 2024 |
$8.18 |
$24.46B |
$4.06B |
16.6% |
| 2025 |
$8.43 |
$26.98B |
$4.16B |
15.4% |
